Best MRI of one area gastroenterologists in Spain: TOP 31 doctors

Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.

Dr. Aranda received his degree in Medicine and Surgery from the Universidad de Málaga in 1983. He specialized in traumatology and orthopedics at the Department of Traumatology and Surgical Orthopedics of the Instituto Dexeus, Barcelona between 1988 and 1993. under the direction of Dr. Villarrubias.

Throughout his medical practice, Dr.Aranda has worked in leading hospitals in Spain, participated in the medical support of the 1992 Olympics in Barcelona and was a traumatologist in the Federación Española de Motociclismo in the European and World Championships in the period 1982 - 1992.

Dr. Aranda currently concentrates his medical practice on the treatment of pathologies of the hip and foot at Hospital Quironsalud Marbella and is a traumatologist at the Sociedad Sportclinic Marbella, a member of the Spanish Society for Hip Surgery Secca.

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

Onco-Urologist

Oncologist, Specialist in skin cancer treatment

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.

One of the world-renowned pioneers in gastrointestinal surgery. Has developed new techniques for the colon and rectum cancer treatment TaTMEТ and NOTES — applied now around the world.
Has performed over 15,000 surgeries.
Performs over 1,000 interventions a year using minimally invasive techniques.
President of the Association of Surgeons-Endoscopists in Europe.

 CURRICULUM VITAE. José E. Batista-Miranda PhD MD  Jan 2025 

Correspondence (Uroclinica Center) : Via Augusta 158. Barcelona, Spain               

Hospital: Centro Medico Teknon/ Grupo Quironsalud,  Vilana 12. 08021  Barcelona, Spain. 

Phone: 34- 687  99 54 57

Qualification: Qualfied urologist in Spain and UK (GMC specialist list) 

Current position.  Urodynamics Head and Consultant Urologist, CM Teknon, Barcelona, since 1996

                                    Director, Uroclinica Team and Continentia Association ( continentia.org)

                                    Co- director: Functional Urology program UAX University, Madridr     

Previous professional Experience

2005- Senior Clinical Chief in Urodynamics. Hospital Vall d´Hebron. Barcelona. 

1995-2003 Consultant Urologist. Urodynamics and Oncology Units. F. Puigvert, Barcelona.

1994 Fellow in Neuro-Urology. Boston University (Drs. Krane & Siroky) and Harvard´s Children´s Hospital (Dr. Bauer) Boston, USA (La Caixa grant).

1994- Registrar. Bristol Urological Institute,U.K.(Mr. Abrams) (Research Council grant)

Current Professional Practice: experience

Head of Urodynamics: on line reporting of over 2000 studies / year at 5 different locations. 

General urology and functional urology clinic. 

Surgery:

1. Thulim and green-light laser vaporization (first case in Barcelona in 2003) .
2. Holmium enucleation (HOLEP)
3. HIFU focal treatment and MRI fusion biopsies
4. Ambulatory flexible cystoscopy
5. Fistula and incontinece surgery: vesico-vaginal fistula, TVT, bladder augmentation
6. Female urethral surgery: diverticula, para- urethral cysts.
7. Ureteroscopy and laser surgery for stones
8. General pediatric urologic surgery: scrotal and  preputial surgery

Urological and post-graduate training.

1997- PhD Thesis, Aut. Univ. of Barcelona (“Oxybutinin in children”) (Spanish Urol. Ass. Prize)

1994- Certified Urologist (Ministries of Health & Education)

1991-Urology Dept,USC Hospital, Los Angeles, CA.(Dr.Skinner) (Research Council grant)

1989-93- Residency in Urology. Fundacio Puigvert-National MIR program. (Dr. Solé Balcells).

Medical Education 

1981-87-Medical Degree, Universidad Autonoma de Barcelona (UAB). 1st Class Degree.

1985 & 86- Intern. Department of Surgery. Keiserin Elisabeth Spital, Viena, Austria.

1988-ECFMG Certificate (Permannent validation:February 1994)

Publications  

103 papers in journals: including 25 in international Journals (see annex)

Editor of 2 books on clinical cases in Urodynamics. 

Chapters in 4 books.

Co-editor "Impact Spanish Urology"

Translations for Br J Surgery, Advances in Urology, WHO/ICUD consultations . 

Presentations at congresses

45, including 28 at international congresses (Eur. Ass. Urol, Am Urol Ass, ICS, SIU, see annex).

Post-graduate teaching ( President, “Continentia association” www.continentia.org ) 

23 ICS accredited courses on Urodynamics  ( 5 English editions for Crotatia, Slonvenia, Hugary, Romania and Bulgaria) 

9 CME international/ multi specialty study days on functional urology and urogynechology 

Courses and talks at ICS and European Ass. meetings. 

Pre-graduate teaching

2010- Bladder dysfunction module. Faculty of Medicine, Aut. Univ of Barcelona

1990-92 Director: Basic Medical English Course for students. Autonomous Univ. of Barcelona.

1992-93 Clinical tutor in Urology (including seminars) Autonomous Univ. of Barcelona .

Invited / elected committee membership and  post graduate lecturer

WHO´s International Consultation on BPH (1995, 97, 2000)

WHO´s  International Consultation on Incontinence (1999, 2001)

Member, Ethics Committee, BarcelonaMedical College.

Secretary, Institutional Review Board (Ethics Research committee. F. Puigvert)

Clinical tutor ellected by Urology residents.

Invited speaker  in courses / symposiums in Spain, Mexico, Morocco and Italy.

Research projects / IRB approved trials / advisor. 

1993- IPSS validation in Spanish

1994- Epristeride phase III clinical trial (Boston University)

1994- Bladder blood flow evaluation (Boston University)

1995- Cavidox (Quality of life in BPH patients, Almirall Laboratories)

1996- Tamsulosin phase IV clinical trial (Boehringer Laboratories)

1996- Vesica international surgical study (Boston scientific) 

1997- European endourology panel (Boston scientific)

1997- YM 905, phase II clinical trial (Yamanouchi/ Astellas)

1998- present: Detrusor morphometry in obstruction (PhD thesis co-director)

2000- European panel on appropriate management on BPH (Erasmus University)

2001- Quality of life in radical prostatectomy vs brachytherapy. Use of FACT questionnaire.

2004- Effect of Aclidinium in  Urology  ( Almirall laboratories) 

2008- 2015: Nocturia Study ( Astellas Europe)

2012- “Beyond” ( Astellas Multicenter study on Mirabegron) Principal Investigator

2014- Belive ( Astellas post- commercialization study) 

2015- VHEA ( Hiperactive bladder in aging population, multicenter group; Principal investigator)

2019- Flow taker monitorization for nocturia ( Astellas grant)

2022- Idorsia Phase 3 nocturia study

2024- 3 researcher led studies: Ambulatory urodynamics register, Virtual reality, Tensi for overactive blader. 

WHO´s International Consultation on BPH (1995, 97, 2000)

WHO´s International Consultation on incontinence (1999, 2001)

MEMBERSHIP. Spanish Urol.Ass, ICS.

Professional experience

• 2018 – present : Head of the Traumatology Department at the International Orthopaedic Center Hospital Ruber Internacional in Madrid.
• 2000 – 2018 : Specialist in Hip and Knee Surgery at the International Center Hospital Ruber Internacional, Madrid.
• Until 2000 : Deputy Head of the Traumatology Department at the Hospital J. Puerta de Hierro, Madrid.

Education and qualifications

• 1992 : Medical degree from the Faculty of Medicine and Surgery of the Autonomous University of Madrid.
• Specialization in Orthopedic Surgery and Traumatology at the Puerta de Hierro Hospital.

Scientific research and clinical trials

1. Phase 2B : Efficacy and safety study of PD 0348292 for the prevention of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty.
2. CV185-047 : Comparison of the efficacy of apixaban and enoxaparin for the prevention of VTE.
3. CV185-035 : A study of prevention of deep vein thrombosis after hip replacement.
4. PRADAXA® 1160.85 : A study of the efficacy of dabigatran etexilate for the prevention of VTE following hip and knee surgery.
5. PRADAXA® 1160.84 : Evaluation of the safety of dabigatran in patients with moderate renal impairment after total renal arthroplasty.

Learning and Teaching

• 1997–2000 : Associate Professor, Department of Traumatology, Puerta de Hierro Hospital, Madrid.

Specialization and innovation

• Knee replacement : Using the latest generation navigation systems, Rapid Recovery and ERAS protocols for accelerated recovery.
• Hip Replacement : Minimally Invasive Techniques and Improved Restorative Protocols.
• Arthroscopic surgery : Treatment of diseases of the knee and hip joints.
• Non-surgical treatment : Introduction of innovative infiltration techniques for joint pathology.

Recognition and achievements

• 2022 : Included in the Forbes list as one of the 100 best doctors in Spain , recognized for leadership and innovation in joint surgery using navigation technologies.
• Since 2008 : ISO 9001:2008 certification for quality of hip and knee replacement surgeries.

Membership in professional organizations

• International Member of the American Academy of Orthopaedic Surgeons .
• Member of the Spanish Association of Arthroscopy .

The doctor has established himself as a pioneer in the field of joint surgery, introducing innovative technologies such as navigation systems and minimally invasive approaches. His achievements and approach to patient recovery make him one of the leading specialists in Spain.

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

Education

• 1985 – Bachelor of Medicine and Surgery , Complutense University of Madrid.
• 1986-1989 – Specialization in Neurology , Hospital 12 de Octubre, Madrid.
• 1991–1993 – Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
• 1997 – Certification of the American Board of Clinical Neurophysiology .

Professional experience

• 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
• 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
• Since 1998 – Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
• 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
• 2022 – Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

Membership in professional societies

• Since 1991 – Member of the American Academy of Neurology (AAN).
• Since 1991 – Member of the American Epilepsy Society (AES).
• Since 1996 – Member of the American Society of Clinical Neurophysiology .
• Since 1988 – Member of the Spanish Society of Neurology .
• Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
• Since 2006 – Member of the editorial committee and the WFN web portal .
• Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
• Since 2009 – Member of the EFNS Educational Courses Committee.
• 2007–2009 – Member of the EFNS Scientific Committee .
• 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
• 2004–2007 – Delegate of Spain to the EFNS .
• 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

Outstanding Achievements

Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.